{"organizations": [], "uuid": "309bc7c5f12d798d7549f5e8eb5f7d673c53a060", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-opiant-pharmaceuticals-awarded-gra/brief-opiant-pharmaceuticals-awarded-grant-of-approximately-7-4-mln-from-the-national-institutes-of-health-idUSFWN1RV0FM", "country": "US", "domain_rank": 408, "title": "BRIEF-Opiant Pharmaceuticals Awarded Grant Of Approximately $7.4 Mln From The National Institutes Of Health", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-18T15:09:00.000+03:00", "replies_count": 0, "uuid": "309bc7c5f12d798d7549f5e8eb5f7d673c53a060"}, "author": "", "url": "https://www.reuters.com/article/brief-opiant-pharmaceuticals-awarded-gra/brief-opiant-pharmaceuticals-awarded-grant-of-approximately-7-4-mln-from-the-national-institutes-of-health-idUSFWN1RV0FM", "ord_in_thread": 0, "title": "BRIEF-Opiant Pharmaceuticals Awarded Grant Of Approximately $7.4 Mln From The National Institutes Of Health", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "the national institutes of health", "sentiment": "negative"}, {"name": "brief-opiant pharmaceuticals", "sentiment": "negative"}, {"name": "mln from the national institutes of health reuters", "sentiment": "none"}, {"name": "opiant pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 18, 2018 / 12:10 PM / Updated 10 minutes ago BRIEF-Opiant Pharmaceuticals Awarded Grant Of Approximately $7.4 Mln From The National Institutes Of Health Reuters Staff 1 Min Read \nApril 18 (Reuters) - Opiant Pharmaceuticals Inc: \n* OPIANT PHARMACEUTICALS AWARDED GRANT OF APPROXIMATELY $7.4 MILLION FROM THE NATIONAL INSTITUTES OF HEALTH FOR DEVELOPMENT OF OPNT003, INTRANASAL NALMEFENE, FOR TREATMENT OF OPIOID OVERDOSE \n* OPIANT PHARMACEUTICALS-GRANT INCLUDES ABOUT $2.6 MILLION TO BE FUNDED FOR PERIOD ENDING MARCH 31, 2019, WITH BALANCE TO BE FUNDED OVER SUBSEQUENT 2 YEARS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-18T15:09:00.000+03:00", "crawled": "2018-04-18T15:30:31.000+03:00", "highlightTitle": ""}